Multitask machine learning-based tumor-associated collagen signatures predict peritoneal recurrence and disease-free survival in gastric cancer

2024-9-14

Failure of evaluation on ABC classification for gastric cancer screening

2024-9-9

Survival among patients cured from gastric adenocarcinoma compared to the background population

2024-9-4

Correction: An artificial intelligence system for comprehensive pathologic outcome prediction in early gastric cancer through endoscopic image analysis (with video)

2024-9-4

Correction: Development of a reliable surgical quality assurance tool for gastrectomy in oncological trials

2024-8-30

Preclinical toxicological assessment of amido-bridged nucleic acid-modified antisense oligonucleotides targeting synaptotagmin XIII for intra-abdominal treatment of peritoneal metastasis of gastric cancer

2024-8-27

Classification of fundic gland polyps for predicting gastric neoplasms in Helicobacter pylori-negative patients with familial adenomatous polyposis

2024-8-22

Oncological similarities between large type 3 and type 4 tumors in patients with resectable gastric cancer: a propensity score-matched analysis of a multi-institutional dataset

2024-8-22

Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial

2024-8-20

The molecular profile of gastric intraepithelial foveolar type neoplasia based on somatic copy number alterations and multiple mutation analysis

2024-8-12

Impact of early economic activity loss on all-cause mortality in gastric cancer survivors following curative treatment: a nationwide study in Korea

2024-8-12

Management challenges and the role of adjuvant chemotherapy in remnant gastric cancer: an analysis of 313 patients from the KEGG multicenter observational study

2024-8-8

Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy

2024-8-7

Increased cardiovascular disease risk among adolescents and young adults with gastric cancer

2024-7-30

Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy

2024-7-20

Importance of duodenal stump reinforcement to prevent stump leakage after gastrectomy: a large-scale multicenter retrospective study (KSCC DELICATE study)

2024-7-19

Genomic events stratifying prognosis of early gastric cancer

2024-7-19

Safety and feasibility of single-incision laparoscopic distal gastrectomy in overweight and obese gastric cancer patients: a propensity score-matched analysis

2024-7-18

A systematic review on the effectiveness of robot-assisted minimally invasive gastrectomy

2024-7-11

Reply to letter to the editor: “5-year follow-up results of a JCOG1104 (OPAS-1) phase III noninferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer”

2024-7-10

Comment on “a machine learning model for predicting the lymph node metastasis of early gastric cancer not meeting the endoscopic curability criteria”

2024-7-6

Gastric microbiome signature for predicting metachronous recurrence after endoscopic resection of gastric neoplasm

2024-7-6

Comment on “Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study”

2024-7-4

Antibody–drug conjugates in gastric cancer: from molecular landscape to clinical strategies

2024-7-4

An artificial intelligence system for comprehensive pathologic outcome prediction in early gastric cancer through endoscopic image analysis (with video)

2024-7-2

Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma

2024-7-2

The extracellular matrix protein EMILIN-1 impacts on the microenvironment by hampering gastric cancer development and progression

2024-6-28

Outcomes after gastrectomy according to the Gastrectomy Complications Consensus Group (GCCG) in the Dutch Upper GI Cancer Audit (DUCA)

2024-6-28

A mathematical simulation model to determine the optimal endoscopic screening strategy for detection of H. pylori-naïve gastric neoplasms

2024-6-27

Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair

2024-6-26

Discontinuation of neoadjuvant therapy does not influence postoperative short-term outcomes in elderly patients (≥ 70 years) with resectable gastric cancer: a population-based study from the dutch upper gastrointestinal cancer audit (DUCA) data

2024-6-26

Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape

2024-6-17

Comment on: Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study

2024-6-13

Correction: Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study

2024-6-12

Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis

2024-6-11

Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study

2024-6-10

TMEM205 induces TAM/M2 polarization to promote cisplatin resistance in gastric cancer

2024-6-8

CDKN2A somatic copy number amplification in normal tissues surrounding gastric carcinoma reduces cancer metastasis risk in droplet digital PCR analysis

2024-6-1

Impact of chemotherapy delay on long-term prognosis of laparoscopic radical surgery for locally advanced gastric cancer: a pooled analysis of four randomized controlled trials

2024-5-29

Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL/6 J mice

2024-5-28

CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions

2024-5-25

A machine learning model for predicting the lymph node metastasis of early gastric cancer not meeting the endoscopic curability criteria

2024-5-25

YAP inhibition overcomes adaptive resistance in HER2-positive gastric cancer treated with trastuzumab via the AKT/mTOR and ERK/mTOR axis

2024-5-23

Factors associated with the efficacy of first-line nivolumab plus chemotherapy in advanced gastric cancer patients with deficient mismatch repair

2024-5-23

SMARCA4-deficient undifferentiated gastric carcinoma: a case series and literature review

2024-5-22

Development of a reliable surgical quality assurance tool for gastrectomy in oncological trials

2024-5-18

Early gastric cancer with RhoGAP fusion is linked to frequent nodal metastasis and a part of microtubular–mucocellular histology

2024-5-16

Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer

2024-5-14

Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritoneal dissemination

2024-5-9

Adjuvant and post-recurrent treatment patterns in patients with resectable gastric cancer in japan: a retrospective database cohort study

2024-4-30